Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
NCT00306800 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2021-02-18
Summary
The purpose of this study is to compare the efficacy of Photodynamic Therapy (PDT) with methyl aminolevulinate (MAL) cream to PDT with vehicle cream, using the the LED light source Aktilite CL128, in treatment of patients with multiple actinic keratosis (sun-damaged skin) on the face and / or scalp
Conditions
- Actinic Keratosis
Interventions
- PROCEDURE
-
Photodynamic therapy with methyl aminolevulinate cream
Sponsors & Collaborators
-
Galderma R&D
lead INDUSTRY
Principal Investigators
-
David Pariser, MD · Virginia Clinical Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Completion
- 2007-10-31
Countries
- United States
Study Locations
More Related Trials
-
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
NCT02464709 ·Status: COMPLETED ·Phase: PHASE4
-
Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin
NCT03006185 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
NCT04085367 ·Status: COMPLETED ·Phase: PHASE3
-
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
NCT05725213 ·Status: COMPLETED
-
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
NCT01475071 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®
NCT05522036 ·Status: COMPLETED ·Phase: NA
-
New Treatments for Actinic Keratoses of the Scalp
NCT05456334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis
NCT02248298 ·Status: COMPLETED ·Phase: PHASE1
-
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
NCT03642535 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
NCT04269395 ·Status: TERMINATED ·Phase: PHASE3
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3
-
Actinic Keratoses Treatment With Metvix® in Combination With Light
NCT02373371 ·Status: COMPLETED ·Phase: PHASE3
-
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK
NCT00308854 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
NCT05359419 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
NCT07144345 ·Status: RECRUITING ·Phase: PHASE3
-
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis
NCT04396184 ·Status: UNKNOWN ·Phase: NA
-
Daylight-PDT With MAL for AK and Photodamaged Skin
NCT02736760 ·Status: COMPLETED ·Phase: PHASE4
-
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
NCT03511326 ·Status: COMPLETED ·Phase: PHASE4
-
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
NCT02149342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)
NCT01000636 ·Status: COMPLETED ·Phase: PHASE4
-
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
NCT02124733 ·Status: COMPLETED ·Phase: PHASE3
-
Daylight Photodynamic Therapy for Actinic Keratosis
NCT03322293 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses
NCT06545396 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
NCT00472459 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
NCT02647151 ·Status: UNKNOWN ·Phase: PHASE4